Pfizer Inc. has agreed to acquire weight-loss drug startup Metsera Inc. for $10 billion. The deal is an outcome of a ...

By Rishabh Jaiswal, Sabrina Valle and Maggie Fick NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion ...

Pfizer (PFE) wins Metsera (MTSR) buyout after a heated bidding war with Novo Nordisk (NVO), securing a $10B deal for the ...

By Rishabh Jaiswal and Sabrina Valle (Reuters) -Obesity drug developer Metsera has accepted Pfizer's $10 billion acquisition ...

Earlier this year, Pfizer shelved a clinical trial for its own weight-loss drug candidate amid safety concerns and shifted ...

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

After a bidding war erupted between Pfizer and Novo Nordisk over the fledgling obesity drug maker, Metsera decided to side with its original suitor.

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

(Reuters) -Pfizer has submitted a sweetened bid for obesity drug developer Metsera, as its fight against rival Novo Nordisk ...

NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...

Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the matter.